Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Increasing Public Health Awareness Intensifies Global Uptake of Autoimmune Disease Diagnostics

Published: Monday, October 14, 2013
Last Updated: Monday, October 14, 2013
Bookmark and Share
Frost & Sullivan: Hospitals and laboratories look for cost-effective test panels enabling simultaneous autoimmune diseases testing.

Successful autoimmune disease awareness campaigns are encouraging patients to seek clinical diagnostics even for general symptoms such as fatigue and gastrointestinal distress, spurring the global autoimmune disease diagnostics market. The rising incidence of gastrointestinal autoimmune conditions, primarily celiac disease, also promotes testing.

As a result, market revenue is estimated to reach $1.0 billion in 2018 from $712.5 million in 2012, according to the new Global Autoimmune Disease Diagnostics Market analysis from Frost & Sullivan (http://www.lifesciences.frost.com).

The U.S. market will be the highest contributor to the growth of the global autoimmune disease diagnostics market, especially as the Patient Protection and Affordable Care Act expands health coverage to at least 19.5 million people in the country. The increase in the number of beneficiaries will lead to higher diagnostic testing of patients with autoimmune disease symptoms.

“Large advertising campaigns for relatively new autoimmune disease medications treating a wide variety of autoimmune diseases, including rheumatoid arthritis, chronic plaque psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, and polyarticular juvenile idiopathic arthritis improved patient awareness,” said a Frost & Sullivan Healthcare research analyst. “The subsequent growth in testing volumes will prompt clinical laboratories to employ advanced autoimmune disease diagnostic tests.”

However, due to the broad range of symptoms associated with autoimmune diseases, clinicians regularly struggle to derive the correct diagnosis, compelling some physicians to question the value of autoimmune disease diagnostics. In fact, as much as 30 percent of healthy patients test positive incorrectly and undergo unnecessary therapies and procedures.

Moreover, several autoimmune disease diagnostic tests are designed for manual operation, and the shortage of skilled technicians limits uptake. Handling certain therapies such as enzyme-linked immunosorbent assay kits and indirect immunofluorescent assays (IFA) that are often designated as highly complex becomes all the more difficult. This created immense demand for automated diagnostic platforms that facilitate rapid and efficient testing.

“Test panels that enable the simultaneous use of multiple autoimmune disease diagnostics will provide the greatest value,” said the analyst. “Although the price per test may decline, escalating sale volumes will fuel market growth.”

As hospital and reference laboratories globally look to enhance productivity and cost-efficiency, consolidation is an inevitable trend. As a result, vendors must address their customers’ increasing demand for automated diagnostic platforms that enable rapid and efficient laboratory testing.

Global Autoimmune Disease Diagnostics Market is part of the Life Sciences Growth Partnership Service program, which also includes: Industry Financial Review of the U.S. In Vitro Diagnostics (IVD) and Life Science Research Tools Markets, U.S. Market for Rheumatoid Arthritis Pharmacotherapeutics, Overview of Indian In Vitro Diagnostics Market, U.S. Clinical Laboratory Market, and Western European IVD Market, among others.

All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Strong Pipeline of mAbs Biosimilars in the US and Europe Lends Impetus to Global Market
The market is expected to soar from $1.2 billion of 2013 to $24 billion in 2019.
Tuesday, February 04, 2014
New Drug Candidates Hold Tremendous Promise for European HIV Drugs Market
Patients to benefit from potential for improved efficacy in less commonly used types of ARV therapies and one-pill-daily combination drugs.
Wednesday, April 17, 2013
Scientific News
Improving Natural Killer Cancer Therapy
Vanderbilt University researchers discover transcription factor critical for NK cell expansion. Findings could lead to increased therapeutic efficacy.
Molecular Mechanism For Generating Specific Antibody Responses Discovered
Study could spur more ways to treat autoimmune disease, develop accurate vaccines.
Gut Microbiomes Of Infants Have An Impact On Autoimmunity
Exposure to pathogens early in life is beneficial to the education and development of the human immune system.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
COPD Linked to Increased Bacterial Invasion
Persistent inflammation in COPD may result from a defect in the immune system that allows airway bacteria to invade deeper into the lung.
Finding Factors That Protect Against Flu
A clinical trial examining the body’s response to seasonal flu suggests new approaches for evaluating the effectiveness of seasonal flu vaccines.
Vaccinations Are More Effective When Administered In The Morning
Research from the University of Birmingham shows that influenza vaccinations have more protective responses when administered in the morning.
Secrets of a Deadly Virus Family Revealed
Scripps Research scientists uncover the glycoprotein structure of LCMV. The findings could guide development of treatments for Lassa fever.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
Reduced Immune Response Causes Flu Deaths in Older Adults
Yale study suggests that immune response to flu causes death in older people, not the virus.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!